FMC Corporation (FMC) Stock Falls -38% After Major Outlook Cut

Key Takeaways

• FMC shares fell roughly 38% over the last 30 days, declining from a close of $8.09 on October 14 to about $4.98 by mid-November 2026.
• The selloff was driven by an October 15 third-quarter guidance cut, when revenue outlook was slashed from $840–$900 million to $65–$125 million and adjusted EBITDA swung to a projected loss of $510–$565 million.
• Reported Q3 results showed revenue of about $106 million (down roughly 80% year over year) and a GAAP net loss of approximately $2.07 billion.
• Weak crop-protection demand, elevated high-priced inventory held by channel partners, and intensifying generic competition drove about $639 million of revenue and $672 million of adjusted EBITDA commercial-action impacts.
• Several law firms have announced securities-fraud investigations tied to the guidance reset and to capital raises completed earlier in 2026.
• Management has lowered fourth-quarter and full-year guidance and is prioritizing liquidity, cost reduction, and completion of its commercial restructuring.

FMC Corporation (FMC) Company Overview and Market Position

FMC Corporation is a global agricultural sciences company that develops and sells crop protection products, including insecticides, herbicides, and fungicides, along with plant health solutions. The company operates across major agricultural markets in North America, Latin America, Europe, and Asia, serving growers and distribution partners through a portfolio of branded and post-patent products. Investors follow FMC because it is one of the largest pure-play crop protection companies, making its results a closely watched barometer of agricultural demand, channel inventory trends, and pricing conditions across the agrochemical industry. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

FMC Corporation (FMC) Stock Price Performance: Last 30 Days vs. Quarter

Over the last 30 days, FMC shares have fallen approximately 38%, dropping from a closing price of $8.09 on October 14 to around $4.98 in mid-November. The sharpest single-session move occurred on October 15, when the stock fell 30.5% to $5.62 after the company sharply reduced its third-quarter outlook, and shares continued to drift lower into November.

The quarterly picture reflects a sustained downtrend. From roughly $12 to $13 in early September, FMC shares have declined by more than half, as weakening crop-protection demand, elevated channel inventories, and pricing pressure progressively weighed on sentiment before the October guidance reset accelerated the slide. The trend underscores a fundamental deterioration that has unfolded over multiple months rather than a single-day event.

What Drove FMC Stock Price in the Last 30 Days

The dominant catalyst was FMC's October 15 update, which cut third-quarter revenue guidance from $840–$900 million to just $65–$125 million and shifted adjusted EBITDA guidance from a projected profit of $120–$140 million to a loss of $510–$565 million. Management attributed the revision to roughly $625–$675 million of impacts from commercial actions, including price reductions on select products held by channel customers in Brazil, Argentina, the United States, and Canada, and a restructuring of its U.S. pricing and rebate model.

On October 29, the company reported third-quarter revenue of about $106 million, down roughly 80% year over year, with adjusted EBITDA of negative $559 million and a GAAP net loss of approximately $2.07 billion. Results also included non-cash charges, including a $287.5 million impairment of crop protection brands and a deferred-tax valuation allowance. In the following weeks, multiple law firms announced securities-fraud investigations focused on the guidance reset and on equity and debt offerings completed earlier in the year.

What Drove FMC Stock Performance Over the Last Quarter

The broader quarterly decline reflects structural pressures that had been building before October. FMC has faced weaker-than-expected grower demand, constrained margins, and channel partners seeking to hold historically low inventory values amid high financing costs and perceived ample supply. Elevated levels of higher-priced FMC inventory sitting in the channel, combined with rapid market price declines driven by generic competition, limited product movement and replenishment orders. The company's decision to comprehensively address these issues—including transitioning its North America pricing model—created a substantial near-term earnings hit, even as management framed the actions as necessary to restore product flow and longer-term competitiveness.

FMC Stock Forecast Drivers: What Investors Should Watch Next

Investors are likely to monitor whether FMC's commercial actions translate into improved product movement and replenishment demand, as well as progress on the transition to its new North America pricing model over the coming quarters. Fourth-quarter guidance calls for revenue of $1.04–$1.14 billion (excluding India) and adjusted EBITDA of $210–$230 million, while full-year 2026 adjusted EBITDA is forecast at a loss of $104–$124 million. Key watch items include channel inventory normalization, competitive and generic pricing pressure, foreign-exchange effects, covenant and liquidity discussions with lenders, and the outcome of the announced securities investigations. Management's preliminary outlook suggests an adjusted EBITDA recovery toward at least $650 million in 2027, but execution, demand stability, and balance-sheet flexibility will be central to whether those targets are met. From what I see, this is important because execution risks remain high in a challenging environment.

Exploring Automated Trading Strategies

I often review Tickeron’s Trending AI Robots to observe how automated strategies are handling volatile names like FMC. The platform curates top-performing bots across thousands of tickers, offering a focused view of signals suited to different trading styles. This helps me cross-check momentum shifts without relying solely on manual analysis.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Notable companies

Industry description

Market Cap

High and low price notable news

Volume